Directorio de personas
Diego Arango Del Corro

Diego Arango Del Corro

Grado: Doctor/a


darango(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-5667-2016

Grupos

Publicaciones

  • Montero S; Seras-Franzoso J; Andrade F; Martinez-Trucharte F; Vilar-Hernández M; Quesada M; Xandri H; Arango D; Abasolo I; Rafael D; Schwartz S

    Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells.

    Pharmaceutics 12 -. .

    [doi:10.3390/pharmaceutics12020185]

  • Gener P; Montero S; Xandri-Monje H; Díaz-Riascos ZV; Rafael D; Andrade F; Martínez-Trucharte F; González P; Seras-Franzoso J; Manzano A; Arango D; Sayós J; Abasolo I; Schwartz S

    Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells.

    Nanomedicine-Nanotechnology Biology and Medicine 24 102106-102106. .

    [doi:10.1016/j.nano.2019.102106]

  • Martinez-Barriocanal, A; Arango, D; Dopeso, H

    PVT1 Long Non-coding RNA in Gastrointestinal Cancer.

    Frontiers in oncology 10 38-38. .

    [doi:10.3389/fonc.2020.00038]

  • Forteza R; Ahsan MK; Cartón-García F; Arango D; Ameen NA; Salas PJ

    Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects.

    MOLECULAR BIOLOGY OF THE CELL 30 3076-3089. .

    [doi:10.1091/mbc.E18-07-0415]

  • Leng C; Overeem AW; Cartón-Garcia F; Li Q; Klappe K; Kuipers J; Cui Y; Zuhorn IS; Arango D; van IJzendoorn SCD

    Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation.

    Plos Biology 17 -. .

    [doi:10.1371/journal.pbio.3000531]

  • Ruiz de Porras V; Bystrup S; Cabrero-de Las Heras S; Musulén E; Palomero L; Alonso MH; Nieto R; Arango D; Moreno V; Queralt C; Manzano JL; Layos L; Bugés C; Martinez-Balibrea E

    Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.

    Cancers 11 -. .

    [doi:10.3390/cancers11101540]

  • Matos AI; Carreira B; Peres C; Moura LIF; Conniot J; Fourniols T; Scomparin A; Martínez-Barriocanal Á; Arango D; Conde JP; Préat V; Satchi-Fainaro R; Florindo HF

    Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.

    JOURNAL OF CONTROLLED RELEASE 307 108-138. .

    [doi:10.1016/j.jconrel.2019.06.017]

  • Gener P; Rafael D; Seras-Franzoso J; Perez A; Pindado LA; Casas G; Arango D; Fernández Y; Díaz-Riascos ZV; Abasolo I; Schwartz S

    Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells.

    Cancers 11 -. .

    [doi:10.3390/cancers11081058]

  • Rafael D; Gener P; Andrade F; Seras-Franzoso J; Montero S; Fernández Y; Hidalgo M; Arango D; Sayós J; Florindo HF; Abasolo I; Schwartz S; Videira M

    AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.

    DRUG DELIVERY 25 961-972. .

    [doi:10.1080/10717544.2018.1461276]

  • Gener P; Seras-Franzoso J; Callejo PG; Andrade F; Rafael D; Martínez F; Montero S; Arango D; Sayós J; Abasolo I; Schwartz S

    Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells.

    Stem Cells International 2018 4516454-4516454. .

    [doi:10.1155/2018/4516454]

  • Serrano-Candelas E; Ainsua-Enrich E; Navinés-Ferrer A; Rodrigues P; García-Valverde A; Bazzocco S; Macaya I; Arribas J; Serrano C; Sayós J; Arango D; Martin M

    Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.

    MOLECULAR ONCOLOGY 12 1383-1397. .

    [doi:10.1002/1878-0261.12332]

  • Tögel L; Nightingale R; Wu R; Chüeh AC; Al-Obaidi S; Luk I; Dávalos-Salas M; Chionh F; Murone C; Buchanan DD; Chatterton Z; Sieber OM; Arango D; Tebbutt NC; Williams D; Dhillon AS; Mariadason JM

    DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.

    SCIENTIFIC REPORTS 8 1767-1767. .

    [doi:10.1038/s41598-018-20176-9]

Proyectos

  • Nueva aproximación terapéutica para el cáncer colorectal.
  • Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
  • Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
  • Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
  • Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
  • Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
  • Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy